News
Why Shares of BioLife Solutions Are Slumping on Wednesday
Shares of BioLife Solutions (NASDAQ: BLFS) were down by more than 27% as of 1:15 p.m. on Wednesday after the healthcare company posted its second-quarter earnings report. The stock is down more than
Why MannKind Stock Soared 19% Higher on Tuesday
Commercial-stage biotech MannKind (NASDAQ: MNKD) was a top choice of investors on the second day of the trading week. Tuesday saw MannKind's share price leap by almost 19%, making it stand out on a
CorMedix (CRMD) Q2 2023 Earnings Call Transcript
Image source: The Motley Fool.
CorMedix (NASDAQ: CRMD)Q2 2023 Earnings CallAug 08, 2023, 8:30 a.m. ET
Operator
Source Fool.com
Why Shares of Enanta Pharmaceuticals Are Dropping Tuesday
Shares of Enanta Pharmaceuticals (NASDAQ: ENTA) were down more than 9% as of 11:45 a.m. on Tuesday after the clinical-stage biotech released fiscal third-quarter earnings on Tuesday. The stock is
Why Eli Lilly, Novo Nordisk, and Viking Therapeutics Are On Fire Today
Weight loss drugmakers are having an exceptionally strong trading session today. As of 10:32 a.m. ET Tuesday morning, Eli Lilly (NYSE: LLY) was up by a noteworthy 16.7%, Novo Nordisk (NYSE: NVO) was
MannKind (MNKD) Q2 2023 Earnings Call Transcript
Image source: The Motley Fool.
MannKind (NASDAQ: MNKD)Q2 2023 Earnings CallAug 07, 2023, 5:00 p.m. ET
Operator
Source Fool.com
Why Shares of Mesoblast Are Down Monday
Shares of Mesoblast (NASDAQ: MESO) were down by more than 15% as of 11:45 a.m. ET on Monday, just days after the healthcare stock plunged more than 61% on bad news regarding one of its lead therapy
Axsome Therapeutics (AXSM) Q2 2023 Earnings Call Transcript
Image source: The Motley Fool.
Axsome Therapeutics (NASDAQ: AXSM)Q2 2023 Earnings CallAug 07, 2023, 8:00 a.m. ET
Operator
Source Fool.com
3 Fantastic Growth Stocks to Buy in August
What's a great thing to do during the hot month of August? One option is to find somewhere cool. Another is to invest in stocks that could deliver their own kind of sizzle.
We asked three Motley
Why Shares of Mesoblast Are Plunging Friday
Shares of Mesoblast (NASDAQ: MESO) were down more than 61% as of 2:15 p.m. on Friday. The pharmaceutical stock is down more than 54% so far this year.
Mesoblast focuses on allogeneic cellular
Dynavax Technologies (DVAX) Q2 2023 Earnings Call Transcript
Image source: The Motley Fool.
Dynavax Technologies (NASDAQ: DVAX)Q2 2023 Earnings CallAug 03, 2023, 4:30 p.m. ET
Operator
Source Fool.com
Geron (GERN) Q2 2023 Earnings Call Transcript
Image source: The Motley Fool.
Geron (NASDAQ: GERN)Q2 2023 Earnings CallAug 03, 2023, 4:30 p.m. ET
Aron Feingold
Source Fool.com
Why Coherus BioSciences Stock Popped Today
Shares of Coherus BioSciences (NASDAQ: CHRS) soared 17.7% on Thursday, according to data provided by S&P Global Market Intelligence, after the biotech company announced better-than-expected
Karyopharm Therapeutics (KPTI) Q2 2023 Earnings Call Transcript
Image source: The Motley Fool.
Karyopharm Therapeutics (NASDAQ: KPTI)Q2 2023 Earnings CallAug 02, 2023, 8:00 a.m. ET
Operator
Source Fool.com
Why Novavax Stock Zoomed 13% Higher on Monday
News of a fresh COVID-19 surge sent numerous stockholders into the shares of vaccine maker Novavax (NASDAQ: NVAX) on the first trading day of the week. As a result, Novavax's shares popped more than
Why Shares of Evolus Are Jumping Thursday
Shares of Evolus (NASDAQ: EOLS) were up more than 25% as of 11 a.m. ET after the company reported record quarterly revenue and increased guidance. The stock is up 31% so far this year.
Evolus is a
EQS-News: Biotest AG: Biotest increases EBIT to Euro 19.8 million
3 Small-Cap Stocks That Could Be Big-Time Winners
Think small. It's one of the best ideas for investors seeking to reap returns that trounce the overall market.
Three Motley Fool contributors identified small-cap stocks that they think could
Is Novavax Stock a Buy Now?
Over the past three years, Novavax (NASDAQ: NVAX) has lost an astonishing 92% of its value on the market. The reason for that is no secret. The biotech quickly established itself in the race to
2 Concerning Numbers Novavax Investors Shouldn't Ignore
Shares of Novavax (NASDAQ: NVAX) have been jumping in the past month, and they are up around 25% since April. There's an influx of money coming its way due to unused COVID shots in Canada, which
Why Shares of ImmunityBio Were Up on Wednesday
Shares of ImmunityBio (NASDAQ: IBRX) were up 10% at 11:40 a.m. ET on Wednesday. The clinical-stage biotech company focuses on cell therapies and immunotherapy platforms, including vaccines and
2 Biotech Stocks That Could Make You Richer
When looking for stocks that can make one richer, investors often start with names they know. The problem is that the names they know also tend to be the names that everyone knows, and these stocks
Why Novavax Stock Tumbled 28% in the First Half of 2023
Shares of Novavax (NASDAQ: NVAX) lost 28% of their value in the first six months of the year, according to data from S&P Global Market Intelligence, extending a downtrend that began in early 2022
Got $500? 3 Growth Stocks to Buy That Could Double Your Money
Make money. That's every investor's goal. How each person chooses to achieve that goal makes the difference in exactly how much money they make and how long it takes to make it.
Some stocks are
2 Hot Stocks Up 30% This Year That Wall Street Thinks Can Still Go Higher
The S&P 500 is up 15% this year, and there are many stocks that have been performing much better than that. Shares of Hims & Hers Health (NYSE: HIMS) and Viking Therapeutics (NASDAQ: VKTX) have been